OGN Organon & Co.: Business Value

This daily price chart for Organon & Co. (OGN) reflects an enterprise value of 11031.88. The business is based on partnerships with research centers and the acquisition of licenses to advance women's healthcare. The company's environmental policy relies on packaging recycling and water purification, while its R&D centers develop new endometriosis treatments and modern biosimilars.

OGN Organon & Co: Enterprise Value in the range 11/23/2025 - 10/28/2026

Analytical breakdowns for Organon & Co.

- price and consensus price forecast:

Price Rate Chart Organon & Co|OGN - Price Target Chart

- market capitalization data:

Market Capitalization Organon|OGN - Total Company Value

- book capitalization data:

Share Book Value Organon|OGN - Book Capitalization|Market Value to Book Value organon.com|OGN - Company Total Assets

- debt and liquidity data:

Total Debt to Capital Organon & Co.|OGN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital organon.com|OGN - Company Debts|Debt to Book Value Organon

Fundamental company valuation:OGN (Organon & Co)

This metric aggregates market capitalization and net debt to determine the total acquisition cost of the business, accounting for liquid assets. By analyzing the enterprise value, an investor can discern the real price of Organon & Co. (OGN) assets, which may be overvalued amid geopolitical risks and drug logistics disruptions, making the enterprise value trend a critical indicator of investment resilience.

Who Organon & Co. competes with

Dare Bioscience - Full Takeover Company Value|TherapeuticsMD Corp (TXMD) - Total Company Value|PTN: Business Value